Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 4 actions are handled by 4 distinct examiners, meaning no single examiner is managing more than one matter. The portfolio is active across 3 distinct art units, suggesting the foundation's research spans several specialized pharmaceutical or biological disciplines. This variety in art units indicates that the foundation's 4 pending actions are being evaluated by different specialized groups within the patent office.
FOLEY, SHANON A is the busiest examiner, currently overseeing 1 pending office action. Since the 4 pending actions are split among 4 distinct examiners, the workload is balanced. The presence of 3 distinct art units for these 4 actions indicates that while the examiners are different, there is some concentration of technical focus within the broader Biotechnology & Pharmaceuticals area. For practitioners, this distribution means that the success of the 4 pending office actions depends on the independent decisions of 4 different examiners across 3 specialized units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FOLEY, SHANON A | 1 | 73.3% | +18.1% |
| SALVOZA, M FRANCO G | 1 | 68.4% | +30.0% |
| HORLICK, KENNETH R | 1 | 78.9% | +15.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 9d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18176909 | Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor | HORLICK, KENNETH R | 4d overdue |
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 9d |
| 18739648 | IRRADIATION-INACTIVATED POLIOVIRUS, COMPOSITIONS INCLUDING THE SAME, AND METHODS OF PREPARATION | FOLEY, SHANON A | — |
| Art Unit | Apps |
|---|---|
| 1672 | 1 |
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18739648 | IRRADIATION-INACTIVATED POLIOVIRUS, COMPOSITIONS INCLUDING THE SAME, AND METHODS OF PREPARATION | FOLEY, SHANON A | — | §102§103§112DP | Non-Final OA | — | Pending | Jun 11, 2024 |
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | SALVOZA, M FRANCO G | 1672 | §103§112 | Final Rejection | 9d | Pending | Oct 25, 2023 |
| 18176909 | Methods of Differentiating a Malignant Tumor from a Non-Malignant Tumor | HORLICK, KENNETH R | 1681 | §112 | Final Rejection | 4d overdue | Pending | Mar 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial